News Image

Top movers in Monday's session

By Mill Chart

Last update: Apr 1, 2024

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Gainers

TickerChangeComment
PLUR638.0%In an impressive move, PLURI INC's (NASDAQ:PLUR) shares recorded a 638.0% increase, closing at $5.98 during Monday's session. In the last 3 months the share price increased with 39.09%.
CXAI145.0%CXAPP INC's (NASDAQ:CXAI) stock price increased by 145.0% to $6.0. Shareholders saw the stock price going 89.92% higher in the past 3 months.
CXAIW117.0%KINS TECH GROUP CL A -CW25's (NASDAQ:CXAIW) stock price is advancing with 117.0% to a price of $0.33. Shareholders saw the stock price going 23.9% lower in the past month.
SBFM73.55%SUNSHINE BIOPHARMA INC's (NASDAQ:SBFM) stock price displayed strong growth, advancing 73.55% and reaching $0.1 during Monday's session. In the last 3 months the share price dropped with 77.72%.
TPST45.27%TEMPEST THERAPEUTICS INC's (NASDAQ:TPST) stock price displayed strong growth, advancing 45.27% and reaching $5.68 during Monday's session. In the last 6 months the stock gained 1.0K%.
IMCC39.66%IM CANNABIS CORP's (NASDAQ:IMCC) shares rose 39.66% to $0.74 during Monday's session. In the last month the share price increased with 60.95%.
NXL38.57%NEXALIN TECHNOLOGY INC's (NASDAQ:NXL) shares rose 38.57% to $1.94. The stock is trading 351.0% higher than a month ago.
XLO37.04%With a 37.04% surge, XILIO THERAPEUTICS INC's (NASDAQ:XLO) stock price reached $1.48 during Monday's session, signaling positive momentum. In the last month the share price increased with 52.33%.
ONDS31.96%ONDAS HOLDINGS INC's (NASDAQ:ONDS) shares rose 31.96% to $1.28. ONDAS HOLDINGS INC released earnings Yesterday. In the last month the stock lost 23.61%.
CNTB30.36%CONNECT BIOPHARMA HOLDINGS L's (NASDAQ:CNTB) shares soared 30.36% to $2.27 during Monday's session. The stock is trading 47.46% higher than a month ago.

Our top gainers page will show you the full list.

Today's top losers

TickerChangeComment
IRON-48.06%DISC MEDICINE INC's (NASDAQ:IRON) stock price faced a 48.06% decline, reaching $32.34 during Monday's session. Earlier today the company had a press release: Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP).
ORGS-37.8%During Monday's session, ORGENESIS INC's (NASDAQ:ORGS) shares took a tumble, falling 37.8% to $0.51. In the last month the share price increased with 28.4%.
BIOR-33.64%BIORA THERAPEUTICS INC's (NASDAQ:BIOR) stock price is declining with 33.64% to a price of $0.73. Earlier today the company had a press release: Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules.
SHCR-31.44%SHARECARE INC's (NASDAQ:SHCR) shares fell 31.44% to $0.53. In the last 3 months the share price dropped with 28.94%.
NDRA-29.1%Investors witnessed a 29.1% decrease in ENDRA LIFE SCIENCES INC's (NASDAQ:NDRA) stock price, which closed at $0.41 during Monday's session. Shareholders saw the stock price going 48.21% lower in the past month.
CZOO-27.74%Investors witnessed a 27.74% drop in CAZOO GROUP LTD's (NYSE:CZOO) stock price, which closed at $8.67 during Monday's session. Shareholders saw the stock price going 176.0% higher in the past month.
VVOS-27.33%VIVOS THERAPEUTICS INC's (NASDAQ:VVOS) stock price is declining with 27.33% to a price of $3.51. In the last 3 months the stock lost 61.17%.
NVVE-27.29%NUVVE HOLDING CORP's (NASDAQ:NVVE) stock price encountered a 27.29% decline, reaching $0.8 during Monday's session. Shareholders saw the stock price going 23.57% higher in the past month.
SBEV-24.61%During Monday's session, SPLASH BEVERAGE GROUP INC's (NYSEARCA:SBEV) shares took a tumble, falling 24.61% to $0.35. The stock is trading 28.9% lower than a month ago.
BLRX-23.18%BIOLINERX LTD-SPONS ADR's (NASDAQ:BLRX) stock price is declining with 23.18% to a price of $0.86. In the last 3 months the stock lost 28.66%.

For the full top loser list go to our top losers page.

Back

TEMPEST THERAPEUTICS INC

NASDAQ:TPST (5/1/2024, 7:00:01 PM)

After market: 3.7 +0.08 (+2.21%)

3.62

+0.15 (+4.32%)

TPST News

News Image5 days ago - Tempest TherapeuticsTempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Image5 days ago - Tempest TherapeuticsTempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing...

News Image23 days ago - Tempest TherapeuticsTempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
News Image23 days ago - Tempest TherapeuticsTempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting

BRISBANE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing...

News Imagea month ago - Tempest TherapeuticsTempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
News Imagea month ago - Tempest TherapeuticsTempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications

TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised...

News Imagea month ago - InvestorPlaceTPST Stock Earnings: Tempest Therapeutics Beats EPS for Q4 2023

TPST stock results show that Tempest Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderTPST Stock Earnings: Tempest Therapeutics Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tempest Therapeutics (NASDAQ:TPST) just reported results for the fourth quarter...

News Imagea month ago - Tempest TherapeuticsTempest Reports Year End 2023 Financial Results and Provides Business Update
News Imagea month ago - Tempest TherapeuticsTempest Reports Year End 2023 Financial Results and Provides Business Update

Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard...

News Image2 months ago - Glancy Prongay & Murray LLPGlancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
News Image2 months ago - Tempest TherapeuticsTempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
TPST Links
Follow us for more